SERPINA7 and metabolic dysfunction-associated steatohepatitis: Collectively, our findings demonstrate that hFGF1<sup>ΔHBS</sup> exerts direct hepatoprotective effects and that AAV8-TBG-mediated liver-directed hFGF1<sup>ΔHBS</sup> delivery represents a safe and effective strategy for treating MASH.